Evidence map›Paper›PMID 42774950›Full record

ArticleBig data and cognitive computing2026

SemNet Explorer: An Evidence-Grounded Knowledge Graph-LLM Framework for Multi-Scale Mechanistic Reporting Across Biomedical Domains.

Xin He, David Camacho, Lama Moukheiber, Meghna Iyer, Benjamin Zhao, Christophe Ye, Batuhan Nursal, Xinyu Guo, Albert J B Lee, Cassie S Mitchell

Abstract read
In one paragraph

Article in Big data and cognitive computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xin HeLaboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.
David CamachoLaboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.
Lama MoukheiberLaboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.
Meghna IyerLaboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.
Benjamin ZhaoLaboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.ORCID 0009-0008-3039-3235
Christophe YeLaboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.
Batuhan NursalLaboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.
Xinyu GuoLaboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.
Albert J B LeeLaboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.ORCID 0000-0002-4480-6327
Cassie S MitchellLaboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.ORCID 0000-0002-5472-6355

Funding

Regulatory and Human Study Operations (RHSO) Core CU19AG065169 · NIA · UNIVERSITY OF ARIZONA · PI HUENTELMAN, MATT · 2021 to 2025
$59.8M
The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's DiseaseR01AG070937 · NIA · EMORY UNIVERSITY · PI LAH, JAMES J · 2021 to 2025
$35.2M
Inflamm-aging of osteoprogenitor cells: A therapeutic target for improved bone healing - Resubmission - 1 - Revision - 3R01AG056169 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEUCHT, PHILIPP · 2018 to 2022
$2.4M
Integrative predictive medicine to identify disease causes, develop cures, and optimize patient careR35GM152245 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI Cassie S Mitchell · 2024 to 2026
$1.1M
Inflamm-aging of osteoprogenitor cells: A therapeutic target for improved bone healingR56AG056169 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEUCHT, PHILIPP · 2023 to 2023
$347k
NIA NIH HHS R01 AG056169NIA NIH HHS R01 AG070937NIA NIH HHS R56 AG056169NIA NIH HHS U19 AG065169NIGMS NIH HHS R35 GM152245
6 · The paper itself

Abstract

Background: Mechanistic reporting from large-scale biomedical knowledge graphs remains challenging, particularly when integrating structured graph evidence with large language model (LLM)-based explanation in a reproducible and auditable manner. Existing approaches either rely on manual synthesis of graph-derived results or generate unconstrained narratives that lack traceability to underlying evidence. Methods: We present Results: SemNet Explorer produces stable region decompositions and interpretable report scaffolds across molecular (AAPP), disease-level (DSYN), and pharmacologic (PHSU) representations. For global reports, explicit evidence grounding improves expression quality more consistently than content accuracy, with benefits dependent on evidence density and semantic abstraction. In contrast, anchor-centric reports show consistent improvements in both content and expression under stronger, mediator-constrained prompting. These findings are supported by both pairwise ablation comparisons and absolute score analyses. Conclusions: SemNet Explorer establishes a generalizable unified framework and interactive platform for transforming knowledge graph evidence into reproducible mechanistic narratives across biomedical domains, including multimorbidity analysis, comparative pathophysiology, drug repurposing, and adverse event discovery. The results demonstrate that effective knowledge graph-LLM integration requires adaptive, context-dependent evidence grounding rather than fixed prompting strategies.

Indexed as

adaptive promptingadverse event analysiscomparative pathophysiologydrug repurposingevidence groundinggraph-based reasoningknowledge graphlarge language modelsmechanistic reportingmultimorbidityprocess enrichmentSemNet 2.0Venn decomposition

Identifiers

PMID42774950
PMCPMC13596072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.